Metarrestin storage and stability testing services
Ended Awarded Last action
- Contract number
- 75N91023F00001
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Recro Pharma, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $78,600
Award facts
- Opportunity
-
- 75N91023Q6688366 Solicitation number
- Contract value 100% obligated
- $78,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
Societal Cdmo San Diego, LLC was awarded a $78,600 firm fixed price delivery order against the National Cancer Institute Cooperative Agreement for Cancer Target Discovery and Preclinical Validation Studies master indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health. Under the delivery order, Societal Cdmo San Diego, LLC will provide metarestin storage and stability testing services for the National Cancer Institute, conducting drug product development studies from September 2023 through May 2024 in San Diego, California. As a division of Recro Pharma, Inc., Societal Cdmo San Diego, LLC will leverage its expertise in preclinical oncology services to support the National Cancer Institute's cancer research mission.
Quick answers
Who was awarded contract 75N91023F00001?
75N91023F00001 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on September 15, 2023.
How much is contract 75N91023F00001 worth?
The government has obligated $78,600 on 75N91023F00001.
Is contract 75N91023F00001 an order under another contract?
Yes. 75N91023F00001 is a delivery order under HHSN271201700020I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N91023F00001 competed?
The extent of competition for 75N91023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award